Eva Schenkman/LinkedIn
Oct 15, 2025, 08:54
Eva Schenkman: Is Metabolomics Making a Return?
Eva Schenkman, Adjunct Professor at Eastern Virginia Medical School, shared a post on LinkedIn:
“What do you think? I remember metabolomics make a splash about 10 years ago then it all faded away. Seems like it is coming back again.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Nov 6, 2025, 12:13Marco Zaccaria: Next LejEndo Dives Into ICG Innovation in Surgery
-
Nov 6, 2025, 12:04Silvia Alvarez: Do Endometriosis or Adenomyosis Affect Oocyte Quality and Pregnancy Rates?
-
Nov 6, 2025, 11:59Mary Mulcahey: Culture Eats Strategy and Grit Fuels Growth
-
Nov 6, 2025, 11:46Connection Between Infertility Treatments and Stroke Risk – Reproduction and Fertility
-
Nov 6, 2025, 00:03Fertility and Sterility: Special Issue Explores Human Embryo Testing and Phased Validation
-
Nov 5, 2025, 23:51William Wallace: How Your Gut Microbes Help Set Your Body’s Internal Clock
-
Nov 5, 2025, 13:34Nibhash Kumar: When Embryos Stop Growing and the Hidden Reasons Behind Early Developmental Arrest
-
Nov 5, 2025, 13:29Ahsan Saeed: DNA From Three Parents Just Stopped a Life-Threatening Disorder Before Birth!
-
Nov 5, 2025, 13:24New Weighted Classification Criteria Refine Antiphospholipid Syndrome Research – Hæmatologi DK